Certified by Founder
Lodge
SpyGlass Pharma, Inc.
start up
United States
- Aliso Viejo, California
- 11/07/2023
- Series C
- $90,000,000
SpyGlass Pharma was Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman. The company is focused on the development of novel treatments for chronic ophthalmic diseases based on technology originally developed in the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine.
- Industry Pharmaceutical Manufacturing
- Website https://www.spyglasspharma.com/
- LinkedIn https://www.linkedin.com/company/spyglasspharma/
Related People
Patrick MooneyFounder
United States -
Southlake, Texas
Experienced Leader with a demonstrated history of success in the pharmaceuticals industry. Skilled in Pharmaceutics, Medical Devices, Operations, Management and People Development.
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)